PLX vs TRMB · P/E 31, rev $53.6M vs P/E 26, rev $1.91B
Protalix Biotherapeutics Inc (PLX) versus Trimble Inc (TRMB) — a side-by-side from cached financials, not a winner call.
Protalix Biotherapeutics Inc (PLX) is a biotechnology company listed on US.
Trimble Inc (TRMB) is a scientific & technical instruments company listed on NASDAQ.
Latest reported PLX revenue for 2026-06-30 was $53.6M. Net income was $22.1M. Revenue was up 59.0% from 2026-03-31 to 2026-06-30. PLX currently screens at market cap $122.6M and trailing P/E 30.8.
Latest reported TRMB revenue for 2026-07-03 was $1.91B. Net income was -$372.8M. TRMB currently screens at market cap $11.39B and trailing P/E 25.6.
PLX currently screens at market cap $122.6M and trailing P/E 30.8. TRMB currently screens at market cap $11.39B and trailing P/E 25.6.
Not investment advice. Open the PLX and TRMB stock pages for the full models.
Not investment advice.